|Year : 2016 | Volume
| Issue : 2 | Page : 59-63
In vivo antimalarial activity of extracts of Tanzanian medicinal plants used for the treatment of malaria
Ramadhani SO Nondo1, Paul Erasto2, Mainen J Moshi1, Abdallah Zacharia3, Pax J Masimba1, Abdul W Kidukuli1
1 Department of Biological and Pre-Clinical Studies, Institute of Traditional Medicine, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania
2 National Institute for Medical Research, Dar es Salaam, Tanzania
3 Department of Parasitology and Medical Entomology, School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania
|Date of Web Publication||6-Apr-2016|
Ramadhani SO Nondo
Department of Biological and Preclinical Studies, Institute of Traditional Medicine, Muhimbili University of Health and Allied Sciences, P. O. Box: 65001, Dar es Salaam
Source of Support: None, Conflict of Interest: None
Plants used in traditional medicine have been the source of a number of currently used antimalarial medicines and continue to be a promising resource for the discovery of new classes of antimalarial compounds. The aim of this study was to evaluate in vivo antimalarial activity of four plants; Erythrina schliebenii Harms, Holarrhena pubescens Buch-Ham, Phyllanthus nummulariifolius Poir, and Caesalpinia bonducella (L.) Flem used for treatment of malaria in Tanzania. In vivo antimalarial activity was assessed using the 4-day suppressive antimalarial assay. Mice were infected by injection via tail vein with 2 Χ 10 7 erythrocytes infected with Plasmodium berghei ANKA. Extracts were administered orally, once daily, for a total of four daily doses from the day of infection. Chloroquine (10 mg/kg/day) and solvent (5 mL/kg/day) were used as positive and negative controls, respectively. The extracts of C. bonducella, E. schliebenii, H. pubescens, and P. nummulariifolius exhibited dose-dependent suppression of parasite growth in vivo in mice, with the highest suppression being by C. bonducella extract. While each of the plant extracts has potential to yield useful antimalarial compounds, the dichloromethane root extract of C. bonducella seems to be the most promising for isolation of active antimalarial compound(s). In vivo antimalarial activity presented in this study supports traditional uses of C. bonducella roots, E. schliebenii stem barks, H. pubescens roots, and P. nummulariifolius for treatment of malaria.
Keywords: In vivo , malaria, medicinal plants, Plasmodium berghei
|How to cite this article:|
Nondo RS, Erasto P, Moshi MJ, Zacharia A, Masimba PJ, Kidukuli AW. In vivo antimalarial activity of extracts of Tanzanian medicinal plants used for the treatment of malaria. J Adv Pharm Technol Res 2016;7:59-63
|How to cite this URL:|
Nondo RS, Erasto P, Moshi MJ, Zacharia A, Masimba PJ, Kidukuli AW. In vivo antimalarial activity of extracts of Tanzanian medicinal plants used for the treatment of malaria. J Adv Pharm Technol Res [serial online] 2016 [cited 2021 Dec 3];7:59-63. Available from: https://www.japtr.org/text.asp?2016/7/2/59/179748
| Introduction|| |
Malaria is a preventable and treatable parasitic disease caused by Plasmodium parasites that is transmitted to humans by infected mosquito vectors.  At present, medicinal plants are the source of effective antimalarial drugs, including artemisinins which are a core component in the currently used antimalarial combination therapies.  Consequently, sustained in vitro and in vivo screening of medicinal plants for their antimalarial activity will help to provide scientific evidence for their use and contribute to the discovery of antimalarial lead molecules for future drug development.
To identify medicinal plants which would provide potential lead compounds, this study evaluated the extracts of Erythrina schliebenii Harms (Fabaceae), Holarrhena pubescens Buch-Ham (Apocynaceae), Phyllanthus nummulariifolius Poir (Euphorbiaceae), and Caesalpinia bonducella (L.) Flem (Caesalpiniacea) for in vivo antimalarial activity in mice infected with Plasmodium berghei ANKA.
| Materials and methods|| |
Diethyl ether (Carlo erba® ), ethanol (Carlo erba® ), methanol (MeOH) (Carlo erba® ), tween 80 (Sigma® ), dichloromethane (DCM) (Carlo erba® ), dimethylsulfoxide (Carlo erba® ), and Giemsa-stain (Sigma) were purchased from Techno-Net Scientific (Dar es Salaam, Tanzania) whereas chloroquine diphosphate was purchased from Sigma (Sigma® , Steinheim, Germany).
Collection of plant materials and extraction
E. schliebenii Harms stem bark (Voucher no. 4661) and H. pubescens Buch-Ham roots (Voucher no. 4665) were collected from Lindi region, whereas P. nummulariifolius Poir whole plant (Voucher no. RN 30) and C. bonducella (L.) Flem roots (Voucher no. RN 93) were collected from Kagera and Dar es Salaam regions, respectively. The plants were identified by a botanist (Mr. Selemani Haji), and the voucher specimens are deposited in the Herbarium at Muhimbili University of Health and Allied Sciences.
Dry powdered plant materials were extracted by maceration using DCM, ethyl acetate (EtoAC), MeOH, or water. Liquid crude extracts were dried by rotary evaporation (at 50°C) to obtain dry crude extracts which were stored at −20°C until they were used.
In vivo antimalarial activity assay
In vivo antimalarial activity of the extracts was determined using the 4-day suppressive test described previously. 
Young adult Theiller's white albino mice, of both sexes, weighing 20-30 g were used. Animals were acclimatized to the laboratory conditions, supplied with food and water ad libitum for 5 days before being used for the test. The animals were handled according to the National and International Guidelines for Handling of Laboratory Animals, and the study received ethical clearance from the Institution review board of the Muhimbili University of Health and Allied Sciences.
Blood stage P. berghei ANKA parasites used in the study were kindly donated by Dr. Lindsay Stewart of the Department of Pathogen Molecular Biology, London School of Hygiene and Tropical Medicine, United Kingdom.
Preparation of infected red blood cells suspension
Donor mice with high parasitemia were anesthetized by diethyl ether; blood was collected by cardiac puncture and diluted with sterile normal saline (0.9% w/v sodium chloride) to make a suspension of 1 × 10 8 infected red blood cells (iRBCs) per mL, which was used to infect test mice.
Inoculation of parasites and administration of extracts
Each mouse was infected by injection via tail vein with 2 × 10 7 iRBCs in 0.2 mL suspension of 1 × 10 8 iRBCs per mL. The extracts were solubilized in 10% Tween 80/6% ethanol, 2% dimethylsulfoxide, or distilled water. Chloroquine was dissolved in normal saline. Three hours post infection, the mice were randomly allocated into groups of 6 mice each: Negative control group received solvent (5 mL/kg/day), positive control group received chloroquine (10 mg/kg/day), and treatment groups received different doses of extracts (200, 400, or 800 mg/kg/day). Dosing was done orally, once daily, starting on the day of infection and continued for a total of four daily doses. Body weight was recorded daily while parasitemia was determined on day 4.
Determination of parasitemia and percentage suppression at day 4
On day 4, tail blood smear was fixed with absolute MeOH and then stained with 10% Giemsa-stain in phosphate buffer (pH 7.2) for 20 min. The parasites were examined under microscope at ×100 oil immersion. Percentage parasitemia was determined by counting the infected erythrocytes in at least 1000 total erythrocytes (infected plus non-infected erythrocytes). The mean percentage suppression of parasitemia for each extract was calculated as follows:
Photographing the parasites
Images were taken with the aid of a light microscope fitted with a camera (Tension® , Axiom) and processed using Tucsen TSView software version 126.96.36.199 (Tucsen, 2013).
Percentage parasitemia suppression and survival time in days were presented as mean ± standard deviation for each group. The mean percentage parasitemia on day 4 and the mean survival time were analyzed statistically using the Student's t-test to identify the differences between treated groups and negative control group. The difference was considered statistically significant at P < 0.05.
| Results|| |
The results of in vivo antimalarial activity revealed that C. bonducella, E. schliebenii, H. pubescens, and P. nummulariifolius exhibited dose-dependent suppression of parasite growth in vivo in mice. At a dose of 400 mg/kg/day, MeOH, EtoAC, and DCM extracts of C. bonducella roots suppressed the parasites growth by 11.36%, 20.01%, and 37.60%, respectively, while the DCM/MeOH (1:1) extract was found to be inactive [Table 1]. Chloroquine given at 10 mg/kg/day caused 100% suppression of parasitemia. Although all extracts of C. bonducella roots reduced parasite growth at this dose, only EtoAC and DCM extracts showed a statistically significant difference (P < 0.05) in mean percentage parasitemia as compared to the negative control group.
|Table 1: In vivo antimalarial activity of Caesalpinia bonducella root extracts at 400 mg/kg/day against Plasmodium berghei ANKA|
Click here to view
Among the extracts of C. bonducella roots tested at 400 mg/kg/day, the DCM extract had the highest activity with 37.60% parasite suppression [Table 1]. Further evaluation of this extract at three different doses revealed dose-dependent effect. It suppressed parasites growth in vivo by 20.70%, 35.3%, and 55.96% at 200, 400, and 800 mg/kg/day, respectively. The mean percentage parasitemia in each of the three groups was significantly different (P < 0.05) from the mean in the negative control group [Figure 1] and [Table 2]. Similarly, the extracts of E. schliebenii, H. pubescens, and P. nummulariifolius exhibited dose-dependent suppression of parasitemia. The aqueous extract of E. schliebenii stem bark suppressed parasitemia by 24.0% at 400 mg/kg/day and by 28.64% at 800 mg/kg/day. The MeOH extract of H. pubescens roots suppressed parasitemia by 32.06% and 43.07% at 400 and 800 mg/kg/day, respectively, while the aqueous extract of P. nummulariifolius whole plant suppressed parasitemia by 9.28% and 29.22% at the dose of 400 and 800 mg/kg/day, respectively [Table 3]. With exception of the DCM extract of C. bonducella roots at 800 mg/kg/day, all other extracts did not increase the mean survival time of the mice as compared to the negative control mice.
|Table 2: In vivo antimalarial activity of dichloromethane root extract of Caesalpinia bonducella at different doses against Plasmodium berghei ANKA|
Click here to view
|Table 3: In vivo antimalarial activity of extracts of Erythrina schliebenii, Holarrhena pubescens, and Phyllanthus nummulariifolius against Plasmodium berghei ANKA|
Click here to view
|Figure 1: Parasitemia at day 4 in mice treated with different doses of dichloromethane root extract of Caesalpinia bonducella. (a) Negative control (2% dimethylsulfoxide); (b) 200 mg/kg/day; (c) 400 mg/kg/day; (d) 800 mg/kg/day; (e) Chloroquine at 10 mg/kg/day|
Click here to view
| Discussion|| |
This study reports the in vivo antimalarial activity of the extracts of E. schliebenii, H. pubescens, P. nummulariifolius, and C. bonducella evaluated using the 4-day suppressive test. The results showed that the extracts of these plant species exhibited dose-dependent suppression of parasites growth in mice. The DCM extract of C. bonducella roots exhibited the highest in vivo antimalarial activity with 55.96% parasite suppression at 800 mg/kg/day compared to all extracts of the other three plant species tested [Table 2] and [Figure 1]. The observed efficacy of DCM extract suggests that less to medium polar compounds present in this extract may be responsible for the antimalarial properties of the roots of C. bonducella. C. bonducella is a medicinal shrub with wide applications common in the tropics and subtropic areas.  The leaves of this plant are reported to be used for the treatment of malaria, diabetes, elephantiasis, splenomegaly, leprosy, and convulsions while the roots are used as anthelmintic, astringent, and for fever. , In previous phytochemical studies, several compounds including caesalpinin 1, caesaldekarin F and G, and demethylcaesaldekarin C have been reported from the roots of C. bonducella.  This group of cassane-type diterpenoid compounds has been reported to have in vitro antimalarial properties. For example, norcaesalpinin E from seeds of C. crista was reported to have good antimalarial activity with IC 50 of 90 nM against Plasmodium falciparum chloroquine resistance - 3/A2.  Furthermore, Innocent et al. had reported in vivo antimalarial activity of 80% ethanolic extract of C. bonducella roots. Therefore, the results of C. bonducella roots observed in this study give additional scientific evidence on the antimalarial properties of this plant.
This study has further shown that the methanolic root extract of H. pubescens inhibited the growth of P. berghei ANKA malaria parasites in vivo with 43% suppression rate [Table 3]. H. pubescens is a tree which is widely studied due to its medicinal properties . The decoction of H. pubescens stem bark is used in Asian countries for amoebic dysentery, diarrhea, asthma, bronchospasm, and malaria.  Furthermore, the decoction of H. pubescens roots was reported as one of the medicinal plant preparations used for treatment of malaria in Tanzania.  The stem bark, seeds, and roots of this plant were reported to be rich in steroidal alkaloid compounds such as conessine, isoconessine, kurchine, conessidine, conkurchicine, and holarrhimine.  Conessine is known for its antiamebic properties. However, some studies reported that methanolic extract of H. pubescens stem bark exhibited in vitro antiplasmodial activity  and conessine, the major steroidal alkaloid from the stem bark, was reported to have both antiplasmodial and in vivo antimalarial activities.  The findings from this study corroborate with the previous reports and therefore support traditional use of H. pubescens for the treatment of malaria.
The aqueous extracts of E. schliebenii and P. nummulariifolius exhibited dose-dependent inhibition of P. berghei ANKA parasites in vivo [Table 3]. There is no literature which has reported any extract or compound with antimalarial properties from these plants. However, extracts and compounds from other species within the same genera have been reported to have antimalarial properties. For example, the EtoAC extract of E. sacleuxii root bark showed good in vitro antiplasmodial activity with IC 50 of 3.0 μg/mL.  The aqueous and methanolic extracts of P. niruri and aqueous and ethanolic extracts of P. amarus whole plant have been reported to possess both in vitro and in vivo antimalarial activities. , This suggests that the antimalarial properties reported in the other plant species within the same genera may support the in vivo activities of E. schliebenii and P. nummulariifolius observed in this study.
| Conclusion|| |
The in vivo antimalarial activity presented in this study support traditional uses of C. bonducella roots, E. schliebenii stem barks, H. pubescens roots, and P. nummulariifolius whole plant for treatment of malaria. Although the extracts demonstrated moderate antimalarial activities, their activities may be enhanced by testing their fractions and isolated compounds. Hence, in vivo guided isolation and characterization of molecules from these plant species responsible for the observed effect is suggested.
Financial support and sponsorship
Swedish International Development Cooperation Agency (Sida) through MUHAS capacity strengthening the program.
Conflicts of interest
There are no conflicts of interest.
| References|| |
National Institute of Allergy and Infectious Diseases (NIAID). Understanding Malaria: Fighting an Ancient Scourge. United States Department of Health and Human Services. NIH Publication No.07-7139; 2007. [https://www.niaid.nih.gov/topics/Malaria/Documents/malaria.pdf]. [Last accessed 2014 Aug 10].
Wells TN. Natural products as starting points for future anti-malarial therapies: Going back to our roots? Malar J 2011;10 Suppl 1:S3.
Peters W. The chemotherapy of rodent malaria, XXII. The value of drug-resistant strains of P. Berghei in screening for blood schizontocidal activity. Ann Trop Med Parasitol 1975;69:155-71.
Moon K, Khadabadi SS, Deokate UA, Deore SL. Caesalpinia bonducella
F - An overview. Rep Opin 2010;2:83-90.
Prasad GP, Trimurtulu G, Reddy KN, Naidu ML. Analytical study of Kuberaksha/Kantaki Karanja Patra Churna [Caesalpinia Bonduc
(L.) Roxb. Leaf powder]. Ayu 2010;31:251-4.
Sigh V, Raghav P. Review on pharmacological properties of Caesalpinia bonduc
L. Int J Med Aromat Plants 2012;2:514-30.
Dickson RA, Fleischer TC, Houghton PJ. Cassane-type diterpenoids from the genus Caesalpinia
. Pharmacogn Commun 2011;1:63-77.
Linn TZ, Awale S, Tezuka Y, Banskota AH, Kalauni SK, Attamimi F, et al.
Cassane- and norcassane-type diterpenes from Caesalpinia crista
of Indonesia and their antimalarial activity against the growth of Plasmodium falciparum
. J Nat Prod 2005;68:706-10.
Innocent E, Moshi MJ, Masimba PJ, Mbwambo ZH, Kapingu MC. Screening of traditionally used plants for in vitro
antimalarial activity in mice. Afr J Tradit Complement Altern Med 2009;6:163-7.
Kumar N, Singh B, Bhandari P, Gupta AP, Kaul VK. Steroidal alkaloids from Holarrhena antidysenterica
(L.) Wall. Chem Pharm Bull (Tokyo) 2007;55:912-4.
Nondo RS, Zofou D, Moshi MJ, Erasto P, Wanji S, Ngemenya MN, et al
. Ethnobotanical survey and in vitro
antiplasmodial activity of medicinal plants used to treat malaria in Kagera and Lindi regions, Tanzania. J Med Plants Res 2015;9:179-92.
Chakraborty A, Brantner AH. Antibacterial steroid alkaloids from the stem bark of Holarrhena pubescens
. J Ethnopharmacol 1999;68:339-44.
Simonsen HT, Nordskjold JB, Smitt UW, Nyman U, Palpu P, Joshi P, et al. In vitro
screening of Indian medicinal plants for antiplasmodial activity. J Ethnopharmacol 2001;74:195-204.
Dua VK, Verma G, Singh B, Rajan A, Bagai U, Agarwal DD, et al.
Anti-malarial property of steroidal alkaloid conessine isolated from the bark of Holarrhena antidysenterica
. Malar J 2013;12:194.
Gessler MC, Nkunya MH, Mwasumbi LB, Heinrich M, Tanner M. Screening Tanzanian medicinal plants for antimalarial activity. Acta Trop 1994;56:65-77.
Mustofa J, Sholikhah EN, Wahyuono S. In vitro
and in vivo
antiplasmodial activity and cytotoxicity of extracts of Phyllanthus niruri
L. herbs traditionally used to treat malaria in Indonesia. Southeast Asian J Trop Med Public Health 2007;38:609-15.
Ajala TO, Igwilo CI, Oreagba IA, Odeku OA. The antiplasmodial effect of the extracts and formulated capsules of Phyllanthus amarus
on Plasmodium yoelii
infection in mice. Asian Pac J Trop Med 2011;4:283-7.
[Table 1], [Table 2], [Table 3]
|This article has been cited by|
||Studies on Activities and Chemical Characterization of Medicinal Plants in Search for New Antimalarials: A Ten Year Review on Ethnopharmacology
| ||Isabela P. Ceravolo,Anna C. Aguiar,Joseph O. Adebayo,Antoniana U. Krettli |
| ||Frontiers in Pharmacology. 2021; 12 |
|[Pubmed] | [DOI]|
||Medicinal plants as a fight against murine blood-stage malaria
| ||Mohamed A. Dkhil,Saleh Al-Quraishy,Esam M. Al-Shaebi,Rewaida Abdel-Gaber,Felwa Abdullah Thagfan,Mahmood A.A. Qasem |
| ||Saudi Journal of Biological Sciences. 2020; |
|[Pubmed] | [DOI]|
||Molecular dynamics simulation analysis of conessine against multi drug resistant Serratia marcescens
| ||Kalyani Dhusia,Kalpana Raja,Pierre Paul Michel Thomas,Pramod K. Yadav,Pramod W. Ramteke |
| ||Infection, Genetics and Evolution. 2019; 67: 101 |
|[Pubmed] | [DOI]|
||Antiplasmodial natural products: an update
| ||Nasir Tajuddeen,Fanie R. Van Heerden |
| ||Malaria Journal. 2019; 18(1) |
|[Pubmed] | [DOI]|
||Antiplasmodial activity of two medicinal plants against clinical isolates of Plasmodium falciparum and Plasmodium berghei infected mice
| ||Serge David Dago Attemene,Sylvain Beourou,Karim Tuo,Albert Alloh Gnondjui,Abibatou Konate,Andre Offianan Toure,Seraphin Kati-Coulibaly,Joseph Alico Djaman |
| ||Journal of Parasitic Diseases. 2017; |
|[Pubmed] | [DOI]|
||The application of Signalling Theory to health-related trust problems: The example of herbal clinics in Ghana and Tanzania
| ||Kate Hampshire,Heather Hamill,Simon Mariwah,Joseph Mwanga,Daniel Amoako-Sakyi |
| ||Social Science & Medicine. 2017; 188: 109 |
|[Pubmed] | [DOI]|
||Anti-plasmodial activity of Norcaesalpin D and extracts of four medicinal plants used traditionally for treatment of malaria
| ||Ramadhani Selemani Omari Nondo,Mainen Julius Moshi,Paul Erasto,Pax Jessey Masimba,Francis Machumi,Abdul Waziri Kidukuli,Matthias Heydenreich,Denis Zofou |
| ||BMC Complementary and Alternative Medicine. 2017; 17(1) |
|[Pubmed] | [DOI]|